Engineers at the Institute of Bioengineering and Nanotechnology (IBN) , a member of the A*STAR’s group of biomedical sciences institutes in Singapore have developed a new material that claims to kill E. coli bacteria quickly and without the adverse health effects of triclosan, a common antibacterial agent that has been restricted in the European Union. IBN Group Leader Yugen Zhang, PhD, and his team, synthesized a chemical compound made

A non-invasive treatment for diabetes monitoring and drug delivery has been developed by South Korean researchers at The Institute for Basic Science (IBS) Center for Nanoparticle Research located in Seoul, South Korea. The device, a graphene-based patch, uses a hybrid of gold-doped graphene and a serpentine gold mesh to measure pH (blood acidity level) and temperature by measuring the amount of glucose in sweat. If abnormally high levels of